Similarly, expression of CXCL8 in tumor tissues and/or serum concentrations of this chemokine were significantly elevated in CRC patients and associated with more advanced stages of tumor, the presence of distant metastases and poorer clinical outcomes, supporting its role as a potential prognostic biomarker and therapeutic target. The gene discussed is CXCL8; the disease is colorectal carcinoma.